Therapeutic adherence in inflammatory bowel disease: User guide from a multidisciplinary modified Delphi consensus
The 12 statements are intended to offer practical guidance to enhance therapeutic adherence in patients with IBD. Patients' profiles at higher risk of non-adherence need prompt recognition and implementation of appropriate strategies by dedicated physicians.
Authors
- Ambrogio Orlando (ORCID: https://orcid.org/0000-0002-5298-2638)
- Maurizio Vecchi (ORCID: https://orcid.org/0000-0003-1558-8604)
- Arianna Dal Buono (ORCID: https://orcid.org/0000-0002-8543-4355)
- Silvio Danese (ORCID: https://orcid.org/0000-0001-7341-1351)
- Alessandro Armuzzi (ORCID: https://orcid.org/0000-0003-1572-0118)
- S. Leone (ORCID: https://orcid.org/0000-0003-1690-8147)
- Flavio Caprioli (ORCID: https://orcid.org/0000-0002-8077-8175)
- Paolo Gionchetti (ORCID: https://orcid.org/0000-0001-9479-5307)
- Fabiana Castiglione
- David Lazzari
Institutions
- Humanitas University (IT)
- Vita-Salute San Raffaele University (IT)
- Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico (IT)
- Ospedale Maggiore (IT)
- Ospedale Vincenzo Cervello (IT)
- Federico II University Hospital (IT)
- Azienda USL di Bologna (IT)
- National Research Council (RO)
- IRCCS Ospedale San Raffaele (IT)
- National Association of Chronic Disease Directors (US)
- IRCCS Humanitas Research Hospital (IT)
- University of Naples Federico II (IT)
- University of Bologna (IT)
Publication Details
- Journal
- Digestive and Liver Disease
- Published
- 2025-05-24
- DOI
- https://doi.org/10.1016/j.dld.2025.04.032
- Citations
- 5
- Primary Topic
- Pharmaceutical studies and practices
- Type
- article
- Field-Weighted Citation Impact
- 17.47